Arvee Laboratories (India) Ltd
NSE:ARVEE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (5.5), the stock would be worth ₹156.81 (6% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 5.8 | ₹166.02 |
0%
|
| 3-Year Average | 5.5 | ₹156.81 |
-6%
|
| 5-Year Average | 5.2 | ₹147.19 |
-11%
|
| Industry Average | 2.8 | ₹80.06 |
-52%
|
| Country Average | 3.3 | ₹92.73 |
-44%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
A
|
Arvee Laboratories (India) Ltd
NSE:ARVEE
|
1.8B INR | 5.8 | 88.2 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
80.3B USD | 17.5 | 31.3 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
13.3T JPY | 3.1 | 27.3 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
75.3B USD | 7.7 | 36.3 | |
| JP |
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
10.8T JPY | 0.7 | 10.5 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
278.5B CNY | 2.6 | 21.3 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
26B CHF | 5.7 | 24.2 | |
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 11.8 | 54.8 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.4T INR | 12 | 61.2 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
24.1B USD | 3 | 15.3 | |
| US |
|
Albemarle Corp
NYSE:ALB
|
22B USD | 2.3 | -32.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 2.1 |
| Median | 3.3 |
| 70th Percentile | 5.5 |
| Max | 4 699.1 |
Other Multiples
Arvee Laboratories (India) Ltd
Glance View
Arvee Laboratories (India) Ltd. provides chemical products, which includes polymer modifiers, contrast media and drug intermediates. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2018-02-22. The firm is primarily engaged in the manufacturing of Polymer Modifiers, Contrast Media Intermediates and Drug Intermediates. The Company’s Polymer Modifiers include 5-Sulfoisophthalic Acid Mono Sodium Salt, Dimethyl 5-Sodiosulfoisophthalate and 5-Sulfoisophthalic Acid Mono Lithium Salt. Its Contrast Media Intermediates include 5-Nitroisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, Monomethyl 5-Nitroisophthalate, 3,5-Diamino Benzoic Acid, Dimethyl 5-Aminoisophthalate and 3,5-Dinitrobenzoic acid. Its Drug Intermediates include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine and 2-Chloro-5-Nitrobenzoic Acid.
